Yvonne GreenstreetFiled
Chief Executive OfficerExecutiveDirectorCIK 1446125
- ALNYALNYLAM PHARMACEUTICALS, INC.Chief Executive Officerfiled Sep 22, 2026
Net · 12 months
-$24.5M
Open-market buys − sales
Sold · 12 months
$24.5M
$0 in 90d · 138 sales on record
Bought · 12 months
$0
$0 in 90d · 0 buys on record
Under 10b5-1
47%
Share of sale value under a trading plan
Last trade
Sep 19, 2026
Filed Sep 22, 2026 · 190 rows
Monthly open-market value · 24 months Filed
- Bought (open market)
- Sold (open market)
Unusual activity Estimated
Whale score 90Whale watch
- 26Exec saleJun 2, 2025
ALNY CEO Yvonne Greenstreet sold $5.9M (10b5-1 plan)
Details
- Insider
- Yvonne Greenstreet
- Company
- ALNYLAM PHARMACEUTICALS, INC.
- Ticker
- ALNY
- Tx kind
- open_market_sale
- Tx date
- Jun 2, 2025
- Shares
- 19,297
- Price
- $306
- Value
- $5.9M
- Is 10b5 1
- Yes
- 28Exec saleMay 30, 2025
ALNY CEO Yvonne Greenstreet sold $7.7M (10b5-1 plan)
Details
- Insider
- Yvonne Greenstreet
- Company
- ALNYLAM PHARMACEUTICALS, INC.
- Ticker
- ALNY
- Tx kind
- open_market_sale
- Tx date
- May 30, 2025
- Shares
- 25,469
- Price
- $304
- Value
- $7.7M
- Is 10b5 1
- Yes
- 50Insider overlapMay 12, 2025
Rep. Jefferson Shreve sold ALNY 18 days before its CEO sold $7.7M
Details
- Politician
- Jefferson Shreve
- Ticker
- ALNY
- Asset
- Alnylam Pharmaceuticals, Inc. - Common Stock (ALNY)
- Tx type
- sell
- Tx date
- May 12, 2025
- Filing date
- Jun 22, 2025
- Amount low
- $15,001
- Amount high
- $50,000
- Amount mid
- $32,501
- Disclosed range
- $15,001 - $50,000
- Reporting lag days
- 41
- Is whale
- No
- Insider trade
- {"insider":{"slug":"yvonne-greenstreet","name":"Yvonne Greenstreet","title":"Chief Executive Officer","short_title":"CEO"},"company":"ALNYLAM PHARMACEUTICALS, INC.","ticker":"ALNY","tx_kind":"open_market_sale","tx_date":"2025-05-30","shares":25469,"price":304,"value":7742576,"is_10b5_1":true}
- Days between
- -18
- Opposite side
- No
Transactions
Independent third-party platform; not affiliated with or endorsed by any member of Congress. Data sourced from publicly available filings and records. Portfolio, holdings, returns, and allocations are estimates and may differ from actual values. Informational and educational only; not investment advice. Shares, prices and post-transaction holdings are exactly as reported on SEC Form 4; the whale score is a model ranking of that filed activity.